Metoder til screening for kolorektal cancer kan forbedres
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Metoder til screening for kolorektal cancer kan forbedres. / Rasmussen, Louise; Jørgensen, Lars Nannestad; Madsen, Mogens Rørbæk; Vilandt, Jesper; Klærke, Michael; Andersen, Jens; Nielsen, Knud T; Khalid, Ali; Laurberg, Søren; Andersen, Claus L; Christensen, Ib Jarle; Brünner, Nils; Nielsen, Hans Jørgen.
I: Ugeskrift for Laeger, Bind 176, Nr. 13, V09130545, 2014, s. 1211-1214.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Metoder til screening for kolorektal cancer kan forbedres
AU - Rasmussen, Louise
AU - Jørgensen, Lars Nannestad
AU - Madsen, Mogens Rørbæk
AU - Vilandt, Jesper
AU - Klærke, Michael
AU - Andersen, Jens
AU - Nielsen, Knud T
AU - Khalid, Ali
AU - Laurberg, Søren
AU - Andersen, Claus L
AU - Christensen, Ib Jarle
AU - Brünner, Nils
AU - Nielsen, Hans Jørgen
PY - 2014
Y1 - 2014
N2 - Screening programmes for colorectal cancer (CRC) are being implemented in various countries worldwide including Denmark. The majority of programmes rely on faecal occult blood testing with subsequent colonoscopy. This approach is challenged by limited compliance, which reduces the efficiency of the screening programme. Current research into improve-ments of screening of CRC includes biological markers identified in blood. Combining blood-based biological markers with clinical and demographical parameters have shown promising results, which may improve the present approach to screening.
AB - Screening programmes for colorectal cancer (CRC) are being implemented in various countries worldwide including Denmark. The majority of programmes rely on faecal occult blood testing with subsequent colonoscopy. This approach is challenged by limited compliance, which reduces the efficiency of the screening programme. Current research into improve-ments of screening of CRC includes biological markers identified in blood. Combining blood-based biological markers with clinical and demographical parameters have shown promising results, which may improve the present approach to screening.
M3 - Tidsskriftartikel
C2 - 25350810
VL - 176
SP - 1211
EP - 1214
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 13
M1 - V09130545
ER -
ID: 137503871